TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 78 filers reported holding TRICIDA INC in Q4 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,741 | -99.8% | 24,468 | -86.1% | 0.00% | -100.0% |
| Q3 2022 | $1,838,000 | +158.9% | 175,426 | +139.1% | 0.01% | +150.0% |
| Q2 2022 | $710,000 | +202.1% | 73,368 | +156.6% | 0.00% | +100.0% |
| Q1 2022 | $235,000 | +267.2% | 28,589 | +328.8% | 0.00% | +100.0% |
| Q4 2021 | $64,000 | +106.5% | 6,667 | 0.0% | 0.00% | – |
| Q3 2021 | $31,000 | -31.1% | 6,667 | -36.3% | 0.00% | -100.0% |
| Q2 2021 | $45,000 | -69.8% | 10,467 | -62.8% | 0.00% | -50.0% |
| Q1 2021 | $149,000 | -69.1% | 28,161 | -58.8% | 0.00% | -71.4% |
| Q4 2020 | $482,000 | -17.9% | 68,300 | +5.5% | 0.01% | -22.2% |
| Q3 2020 | $587,000 | -44.7% | 64,747 | +67.7% | 0.01% | -50.0% |
| Q2 2020 | $1,061,000 | +184.5% | 38,617 | +127.7% | 0.02% | +80.0% |
| Q1 2020 | $373,000 | -71.3% | 16,962 | -50.7% | 0.01% | -58.3% |
| Q4 2019 | $1,298,000 | – | 34,390 | +1719400.0% | 0.02% | – |
| Q3 2019 | $0 | -100.0% | 2 | -100.0% | 0.00% | -100.0% |
| Q1 2019 | $164,000 | +152.3% | 4,259 | +53.8% | 0.01% | +66.7% |
| Q4 2018 | $65,000 | – | 2,769 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |